Evaluation of the Immune Response and the Safety of a Pandemic Influenza Candidate Vaccine (H1N1)

NCT00971425 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

145

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Pandemrix (GSK investigational influenza GSK2340272A vaccine)
BIOLOGICAL: Fluarix™
BIOLOGICAL: Placebo

Sponsor

GlaxoSmithKline